Legacy Education Inc

Análisis de la acción Legacy Education Inc (LGCY)

$11.160

+0.277 (+2.48%)Al cierre

Loading chart…
High
11.700
Open
10.890
VWAP
11.23
Vol
88.71K
Mkt Cap
Low
10.840
Amount
996.55K
EV/EBITDA, TTM
7.39

Legacy Education Inc. is a post-secondary education company, which provides career-focused education in the healthcare field, with certificates and degrees for nursing, medical technicians, dental assisting, business administrative, and several others. It offers a range of educational programs and services to help students achieve their professional goals. It offers programs in career paths, such as healthcare, veterinary, medical information technology, business management, and green technology. It offers post-secondary education services to students through its accredited academic institutions: Desert Medical College (HDMC), Central Coast College (CCC), and Integrity College of Health (Integrity). HDMC offers instruction in thirty-three programs, including ultrasound technician, ultrasound technician associate of applied science degrees, medical billing and coding. CCC offers instruction in healthcare career training programs, and veterinary career training.

AI analysis of Legacy Education Inc (LGCY)

buy

Legacy Education Inc is a good buy right now due to its strong recent earnings performance, with a reported EPS of $0.22 that exceeded expectations by 37.5%, and a significant revenue growth of 15% year-over-year in Q3 2026, reaching $21.4 million. The stock is currently priced at $11.16, which is below the analyst target prices, indicating potential upside. However, the RSI is at 69.472, suggesting it is nearing overbought territory, which could be a risk for short-term investors.

Métricas de valoración

The current forward P/E ratio for Legacy Education Inc (LGCY) is 0.00, compared to its 5-year average forward P/E of 13.88.

Forward P/E

Strongly Undervalued
5Y Average P/E
13.88
Current P/E
0.00
Sobrevalorada
18.27
Infravalorada
9.49

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
8.86
Current EV/EBITDA
7.39
Sobrevalorada
11.24
Infravalorada
6.49

Forward P/S

Fair
5Y Average P/S
1.55
Current P/S
1.47
Sobrevalorada
1.91
Infravalorada
1.18

Cronología de eventos

2026-05-14 (ET)

16:20:00

Company Reports Q3 Revenue of $21.4M

2026-04-24 (ET)

09:40:00

Legacy Education Inc Trading Halted Due to Volatility

2026-02-12 (ET)

16:20:00

Legacy Education Reports Q2 Revenue of $19.2M, Beating Expectations

2025-11-13 (ET)

16:11:40

Legacy Education announces Q1 EPS of 16 cents, surpassing consensus estimate of 15 cents.

2025-09-25 (ET)

16:07:02

Legacy Education announces Q4 EPS of 9 cents, below consensus estimate of 11 cents.

Noticias

LGCY FAQ — answered by Alphio AI

Legacy Education Inc. is a post-secondary education company, which provides career-focused education in the healthcare field, with certificates and degrees for nursing, medical technicians, dental assisting, business administrative, and several others. It offers a range of educational programs and services to help students achieve their professional goals. It offers programs in career paths, such as healthcare, veterinary, medical information technology, business management, and green technology. It offers post-secondary education services to students through its accredited academic institutions: Desert Medical College (HDMC), Central Coast College (CCC), and Integrity College of Health (Integrity). HDMC offers instruction in thirty-three programs, including ultrasound technician, ultrasound technician associate of applied science degrees, medical billing and coding. CCC offers instruction in healthcare career training programs, and veterinary career training. It operates in the Academic & Educational Services sector.

Legacy Education Inc is a good buy right now due to its strong recent earnings performance, with a reported EPS of $0.22 that exceeded expectations by 37.5%, and a significant revenue growth of 15% year-over-year in Q3 2026, reaching $21.4 million. The stock is currently priced at $11.16, which is below the analyst target prices, indicating potential upside. However, the RSI is at 69.472, suggesting it is nearing overbought territory, which could be a risk for short-term investors.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis